Wire · opportunities
Abbott receives US FDA approval for new CardioMEMS HF System capabilities that help ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 7 October 2026 · Fusion42 review
Abbott received FDA approval for enhanced capabilities of its CardioMEMS HF System, including the CardioGuide HF App that allows patients to view pulmonary artery pressure readings on their smartphones and a Dynamic Treatment Plan feature for personalized medication adjustments communicated digitally.
This Wire brief sits within Fusion42's coverage of Digital Health, and 5 sources have reported it between 5 Oct 2026 and 8 Oct 2026.
◆ ◆ The Wire takeaway
You must adapt patient management to include direct digital engagement via Abbott's CardioGuide HF App which shifts care by enabling patients to self-monitor and follow personalised medication changes, reducing hospitalisations risks.
◆ Coverage
5 sources · first reported 5 Oct 2026 · latest 8 Oct 2026
◆ Related on Wire
◆ Topics